FDA Actions to Accelerate and Modernize Early and Late-Stage Clinical Development (opens in new tab)
Learn more about actions to accelerate and modernize clinical research across the full continuum of drug development —from the Investigational New Drug (IND) phase to late-stage pivotal trials.
Read the original article